Arvinas, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. The company develops proteolysis targeting chimeras (PROTAC) targeted prot...
Leadership
Andrew R. Saik
CFO & Treasurer
Angela M. Cacace Ph.D.
Chief Scientific Officer
Randy Teel Ph.D.
CEO, President & Director
David K. Loomis M.B.A.
VP & Chief Accounting Officer
Jeff Boyle
Vice President of Investor Relations
Jared M. Freedberg J.D.
General Counsel & Corporate Secretary
Steve Weiss
Senior VP & Chief Human Resources Officer
Paul McInulty
Senior Vice President of Regulatory Affairs
Kelly Page
Senior VP & Global Head of Oncology Strategy and Program Leadership
